Drug Companies and Physicians Push For Tighter P&T Committee Standards: Changes to NAIC Model Act Would Restrict Formularies, Too.
نویسنده
چکیده
Tighter P&T committee rules proposed for NAIC model act.
منابع مشابه
Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs.
Drug companies push to rein in 340B discount drugs.
متن کاملHHS Proposes Formulary Changes For Marketplace Health Plans: P&T Committees Would Take On a More Visible Role.
The federal government is proposing changes to the pharmacy benefit of marketplace plans in 2016 that (among other things) would increase the power of P&T committees, revise minimum "drug count" standards, and tighten conflict-of-interest rules.
متن کاملQualified insurance plans on health exchanges may reduce drug availability: hospital pharmacies could face new pressures.
With the Patient Protection and Affordable Care Act going into effect in 2014, hospitals are scrambling to ensure that their formularies meet federal standards.
متن کاملFinal Formulary Rules for Health Exchanges Nettle Drug Manufacturers: Health Plans and PBMs Block Broader Drug Access For Patients and Businesses.
188 P&T® • April 2013 • Vol. 38 No. 4 Pharmaceutical companies failed to convince the Obama administration to force health plans to offer wider access to brand-name drugs for individuals and small businesses that will be buying policies on the state and federal health exchanges, which start in January 2014. The Patient Protection and Affordable Care Act (PPACA) dictates that all health plans of...
متن کاملAlternate financial incentives in multi-tiered formulary systems to improve accountability for outcomes.
BACKGROUND Drug manufacturer rebates paid to health plans and pharmacy benefit management companies have come under increased public scrutiny. Over the past several years, numerous articles have appeared in the literature encouraging a shift to a more quality-based decision-making process for health plan drug formularies. OBJECTIVE To propose a new basis for formulary placement decisions that...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 41 4 شماره
صفحات -
تاریخ انتشار 2016